Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

148 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Clinical correlation of the CLSI susceptibility breakpoint for piperacillin- tazobactam against extended-spectrum-beta-lactamase-producing Escherichia coli and Klebsiella species.
Gavin PJ, Suseno MT, Thomson RB Jr, Gaydos JM, Pierson CL, Halstead DC, Aslanzadeh J, Brecher S, Rotstein C, Brossette SE, Peterson LR. Gavin PJ, et al. Among authors: rotstein c. Antimicrob Agents Chemother. 2006 Jun;50(6):2244-7. doi: 10.1128/AAC.00381-05. Antimicrob Agents Chemother. 2006. PMID: 16723596 Free PMC article.
Comparative in vitro activities of ciprofloxacin, gemifloxacin, grepafloxacin, moxifloxacin, ofloxacin, sparfloxacin, trovafloxacin, and other antimicrobial agents against bloodstream isolates of gram-positive cocci.
Hardy D, Amsterdam D, Mandell LA, Rotstein C. Hardy D, et al. Among authors: rotstein c. Antimicrob Agents Chemother. 2000 Mar;44(3):802-5. doi: 10.1128/AAC.44.3.802-805.2000. Antimicrob Agents Chemother. 2000. PMID: 10681365 Free PMC article.
A randomized, open-label, multicenter comparative study of the efficacy and safety of piperacillin-tazobactam and cefepime for the empirical treatment of febrile neutropenic episodes in patients with hematologic malignancies.
Bow EJ, Rotstein C, Noskin GA, Laverdiere M, Schwarer AP, Segal BH, Seymour JF, Szer J, Sanche S. Bow EJ, et al. Among authors: rotstein c. Clin Infect Dis. 2006 Aug 15;43(4):447-59. doi: 10.1086/505393. Epub 2006 Jul 10. Clin Infect Dis. 2006. PMID: 16838234 Clinical Trial.
In-vitro activity of trospectromycin against gram-positive cocci.
Beam TR Jr, Gorzynski EA, Rotstein C, Amsterdam D. Beam TR Jr, et al. Among authors: rotstein c. J Antimicrob Chemother. 1995 Nov;36(5):874-8. doi: 10.1093/jac/36.5.874. J Antimicrob Chemother. 1995. PMID: 8626271 No abstract available.
148 results